Brainstorm Cell Therapeutics (BCLI) Cash from Financing Activities (2010 - 2026)
Brainstorm Cell Therapeutics (BCLI) reported Cash from Financing Activities of $898,000 for Q2 2026, down 66.8% from $2.7 million a year earlier and down 28.2% from the prior quarter.
Powered by 
Analysis
Brainstorm Cell Therapeutics (BCLI) Cash from Financing Activities (2010 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Brainstorm Cell Therapeutics' Cash from Financing Activities came in at $3.24 million, down 52.7% year-over-year; for FY2025, it came in at $6.88 million, down 13.6% from FY2024.
- Cash from Financing Activities has a five-year compound annual growth rate of -38.3% (FY2020 to FY2025).
- By year, Cash from Financing Activities came in at $7.97 million in FY2024 (-58.0%), $18.98 million in FY2023, $238,000 in FY2022 (-96.6%) and $6.97 million in FY2021 (-90.9%).
- Five-year quarterly Cash from Financing Activities spans a low of -$106,000 in Q3 2021 and a high of $7.1 million in Q3 2023.
- Year over year, Cash from Financing Activities has now declined in each of the last three quarters, with an average decline of 39.6% over the last six quarters.
- The high point for year-over-year Cash from Financing Activities in five years was Q1 2025 (growth of 21.5%); the low point was Q4 2024 (a decline of 68.4%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $1.25 million (Q1 2026), $780,000 (Q4 2025) and $313,000 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 8.43 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | -8.78 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | -5.05 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 1.76 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | -2.02 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | -3.89 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | -1.48 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | 2.34 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | -3.66 Bn |
| 10 | Brainstorm Cell Therapeutics | 8.50 Mn | 8.43 Mn | - | 898,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 898,000.00 |
| Mar 31, 2026 | 1.25 Mn |
| Dec 31, 2025 | 780,000.00 |
| Sep 30, 2025 | 313,000.00 |
| Jun 30, 2025 | 2.70 Mn |
| Mar 31, 2025 | 3.09 Mn |
| Dec 31, 2024 | 1.06 Mn |
| Jun 30, 2024 | 4.37 Mn |
| Mar 31, 2024 | 2.54 Mn |
| Dec 31, 2023 | 3.35 Mn |
| Sep 30, 2023 | 7.10 Mn |
| Jun 30, 2023 | 5.30 Mn |
| Mar 31, 2023 | 3.23 Mn |
| Dec 31, 2021 | -34,000.00 |
| Sep 30, 2021 | -106,000.00 |
| Mar 31, 2021 | 7.11 Mn |
| Dec 31, 2020 | 20.94 Mn |
| Sep 30, 2020 | 19.63 Mn |
| Jun 30, 2020 | 7.41 Mn |
| Mar 31, 2020 | 28.96 Mn |
API Access
Brainstorm Cell Therapeutics Cash from Financing Activities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=BCLI&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-from-financing-activities", "ticker": "BCLI", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=BCLI&period=max&api_key=YOUR_API_KEY");
const data = await res.json();